Zen Technologies Q4FY26 Financial Results and Strategic Outlook

Zen Technologies reported its financial results for the quarter ending March 31, 2026. The company recorded a quarterly revenue of ₹178.08 crore and a Profit After Tax of ₹31.53 crore. Despite a muted financial performance for FY26 compared to the previous year, the firm enters FY27 with a strong consolidated order book of ₹1,336 crore, supported by an expanded product portfolio in defense training, anti-drone solutions, and combat robotics.

Quarterly Financial Performance

For the quarter ended March 31, 2026, Zen Technologies achieved a total revenue of ₹200.78 crore, comprising ₹178.08 crore in sales and ₹22.70 crore in other operating revenue. The company reported an EBITDA of ₹73.69 crore with an EBITDA margin of 41.38%. The Profit After Tax (adjusted for non-controlling interest) for the quarter stood at ₹31.53 crore.

Full-Year Fiscal Summary

For the full financial year FY26, the company reported a total revenue of ₹773.11 crore and a full-year EBITDA of ₹332.66 crore. The annual Profit After Tax (adjusted for non-controlling interest) reached ₹193.45 crore. Management noted that while FY26 performance was muted relative to FY25, the company successfully underwent a structural transformation to position itself as a provider of five key defense capabilities.

Order Book and Future Growth

Zen Technologies concluded the fiscal year with a consolidated order book of ₹1,336 crore. This total includes ₹431 crore in new order inflows secured during the final quarter of FY26. The company emphasized that a majority of this current order book is scheduled for execution throughout FY27. With an expanded product portfolio and a favorable domestic policy environment, the company remains optimistic about its positioning for the upcoming fiscal year.

Strategic Transformation

Over the past two years, Zen Technologies has diversified its offerings to include training simulation systems, counter-drone solutions, automated weapons stations, combat robotics, and drones. These capabilities are designed to meet modern battlefield requirements. Additionally, the company highlighted the growing contribution of its subsidiaries to consolidated earnings, confirming the success of its long-term capital allocation strategy.

Source: BSE

Previous Article

MedPlus Health Services Limited Board Meeting Scheduled for Financial Results Approval